SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-23-000008
Filing Date
2023-05-10
Accepted
2023-05-09 17:53:46
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-20230331.htm   iXBRL 10-Q 1050789
2 EX-10.1 nktr2023-03x31xexx1011.htm EX-10.1 65358
3 EX-31.1 nktr2023-03x31xexx311.htm EX-31.1 9524
4 EX-31.2 nktr2023-03x31xexx312.htm EX-31.2 9517
5 EX-32.1 nktr2023-03x31xexx321.htm EX-32.1 5893
11 imagea.jpg GRAPHIC 3651
  Complete submission text file 0000906709-23-000008.txt   4924108

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktr-20230331.xsd EX-101.SCH 37527
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nktr-20230331_cal.xml EX-101.CAL 66092
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nktr-20230331_def.xml EX-101.DEF 167926
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktr-20230331_lab.xml EX-101.LAB 424573
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktr-20230331_pre.xml EX-101.PRE 281405
50 EXTRACTED XBRL INSTANCE DOCUMENT nktr-20230331_htm.xml XML 670859
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 23903617
SIC: 2834 Pharmaceutical Preparations